Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Capricor Therapeutics, Inc. (CAPR) had Normalized Income after Taxes of $-25.91M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-25.91M |
|
-- |
|
-- |
|
$27.72M |
|
$-27.72M |
|
$1.81M |
|
$-25.91M |
|
$-25.91M |
|
$-25.91M |
|
$-25.91M |
|
$-25.91M |
|
|
Normalized Income after Taxes |
$-25.91M |
$-27.72M |
|
$-27.23M |
|
45.71M |
|
45.71M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$124.13M |
|
$8.00M |
|
$9.44M |
|
$133.57M |
|
$28.40M |
|
-- |
|
$0.19M |
|
$28.59M |
|
$104.98M |
|
$104.98M |
|
$104.98M |
|
45.71M |
|
| Cash Flow Statement Financials | |
$-26.56M |
|
$38.44M |
|
$0.07M |
|
$11.29M |
|
$23.24M |
|
$11.95M |
|
$9.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.68% |
|
-24.68% |
|
-19.40% |
|
-24.68% |
|
$2.30 |
|
$-0.64 |
|
$-0.58 |
|